Morris Meredith Teilhet, Coppin Alexandra, Tomavo Stanislas, Carruthers Vern B
The W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA.
J Biol Chem. 2002 Nov 22;277(47):45259-66. doi: 10.1074/jbc.M205517200. Epub 2002 Sep 11.
We have characterized a Kazal family serine protease inhibitor, Toxoplasma gondii protease inhibitor 1 (TgPI-1), in the obligate intracellular parasite Toxoplasma gondii. TgPI-1 contains four inhibitor domains predicted to inhibit trypsin, chymotrypsin, and elastase. Antibodies against recombinant TgPI-1 detect two polypeptides, of 43 and 41 kDa, designated TgPI-1(43) and TgPI-1(41), in tachyzoites, bradyzoites, and sporozoites. TgPI-1(43) and TgPI-1(41) are secreted constitutively from dense granules into the excreted/secreted antigen fraction as well as the parasitophorous vacuole that T. gondii occupies during intracellular replication. Recombinant TgPI-1 inhibits trypsin, chymotrypsin, pancreatic elastase, and neutrophil elastase. Immunoprecipitation studies with anti-rTgPI-1 antibodies reveal that recombinant TgPI-1 forms a complex with trypsin that is dependent on interactions with the active site of the protease. TgPI-1 is the first anti-trypsin/chymotrypsin inhibitor to be identified in bradyzoites and sporozoites, stages of the parasite that would be exposed to proteolytic enzymes in the digestive tract of the host.
我们已对专性细胞内寄生虫刚地弓形虫中的一个卡扎尔家族丝氨酸蛋白酶抑制剂——刚地弓形虫蛋白酶抑制剂1(TgPI-1)进行了特性分析。TgPI-1含有四个预测可抑制胰蛋白酶、胰凝乳蛋白酶和弹性蛋白酶的抑制结构域。针对重组TgPI-1的抗体在速殖子、缓殖子和子孢子中检测到两种多肽,分子量分别为43 kDa和41 kDa,命名为TgPI-1(43)和TgPI-1(41)。TgPI-1(43)和TgPI-1(41)从致密颗粒中持续分泌到排泄/分泌抗原组分以及刚地弓形虫在细胞内复制期间所占据的寄生泡中。重组TgPI-1可抑制胰蛋白酶、胰凝乳蛋白酶、胰腺弹性蛋白酶和中性粒细胞弹性蛋白酶。用抗rTgPI-1抗体进行的免疫沉淀研究表明,重组TgPI-1与胰蛋白酶形成复合物,该复合物依赖于与蛋白酶活性位点的相互作用。TgPI-1是在缓殖子和子孢子中鉴定出的首个抗胰蛋白酶/胰凝乳蛋白酶抑制剂,这两个阶段的寄生虫会在宿主消化道中接触到蛋白水解酶。